Login prior to clicking the links below

SESSION I – IMMUNOTHERAPY UPDATES
Welcome and Introduction of Program Co-Chairs	Anil Kapoor	VIEW
Welcome: Overview Of Program, Speakers and Meeting Objectives	Simon Tanguay, Lori Wood	VIEW
Immune Checkpoint Blockers: Today and Tomorrow	Manuela Schmidinger	VIEW
Decoding the Discussion Between the Immune System and Tumors: A Translator Perspective	Réjean Lapointe	VIEW
SESSION II – CURRENT RESEARCH IN CANADA
CKCis Update Report: Data, Recent Publications and Ongoing Research	Naveen Basappa, Rodney Breau	VIEW
Renal TRACERx: Deterministic Evolutionary Trajectories Govern Primary Tumour Growth	Samra Turajlic	VIEW
Highlights in Kidney Cancer Research in Canada
Renal Cell Carcinoma in the Canadian Indigenous Population	Emily Wong (McMaster)	VIEW
Overexpression of MIR-2355 Revealed SUSD4 as Predicted Target in VHL-Inactivated Renal Cell Carcinoma	Sandra Turcotte (Université de Moncton)	VIEW
Development of a Patient Decision Aid for Complex, Localized Renal Masses	Kristen McAlpine (University of Ottawa)	VIEW
Exploiting Novel Therapeutic Targets to Block Metastasis of Clear Cell Renal Cell Carcinoma	Jan Rudzinski (University of Alberta)	VIEW
Immune Checkpoint Blockades in the Clinic: Unanswered Questions, Optimizing Use, and Patterns of Response	Toni Choueiri	VIEW
Spotlight on KCRNC-Research Trainees
Identification and Translation of Novel Kidney Cancer Immunotherapeutic Targets Through Genetic Screens Using the CRISPR-Cas9 System	Keith Lawson (University of Toronto)	VIEW
Understanding the Attributes of Papillary Renal Cell Carcinoma Subtypes: Molecular Analysis, Biomarker Discovery and Implications to Therapy	Rola Saleeb (St. Michael’s Hospital)	VIEW
Genomics Analysis with Functional Imaging of RCC Patient Derived Xenografts (PDXs) to Determine If There Are Key Genetic Mutations That Are Responsible For a Drug Resistant Phenotype.	Matthew Lowerison (University of Western Ontario)	VIEW
Clinical Trials Update, Opportunities, and Ongoing Projects in Canada	Christian Kollmannsberger	VIEW
LATE BREAKING CANADIAN PROJECTS
Results from Renal Hypothermia During Partial Nephrectomy	Ilias Cagiannos, Rodney Breau	VIEW
2017 CUA Follow-Up Guidelines for Resected RCC	Wes Kassouf	VIEW
Kidney Cancer Canada Updates	Stephen Andrew, Andrew Weller	VIEW
SESSION III: CLINICAL AND BIOLOGICAL GENETICS and BIOMARKERS
Contemporary Role of Cytoreductive Nephrectomy	Stephen Boorjian	VIEW
Tracking Renal Cancer Evolution Reveals Constrained Routes to Metastases	Samra Turajlic	VIEW
Precision Medicine from the Renal Cancer Genome	Yasser Riazalhosseini	VIEW
Emerging Biomarkers of Immune Checkpoint Markers in RCC	Toni Choueiri	VIEW
SESSION V: MOVING FORWARD
Grant Presenters:
Identifying Prognostic and Predictive Biomarkers in Metastatic Renal-Cell Carcinoma: An Exploratory Study of the International Metastatic Renal‐Cell Carcinoma Database Consortium (IMDC) Tissue Biorepository	Shaan Dudani	VIEW
The Preclinical Development of a Novel Formulation to Silence the Expression of Proteins Required for Renal Cell Carcinoma Metastasis	Jan Krzysztof Rudzinski	VIEW
Surveillance of Complex Renal Cysts – The SoCRAtiC Pilot Trial	Patrick Richard	VIEW
Assessing Glioma-Protein Inhibition in Sunitinib-Resistance Using a Tissue-Engineered RCC Patient Derived 3-Dimensional Model	Ninadh D’costa	VIEW
Discussion and Q & A		VIEW
Retroperitoneal Lymph Node Dissection For Renal Cell Carcinoma: Yes, No, or Sometimes?	Stephen Boorjian	VIEW
Group 1: Moving Forward with Clinical Genetics	Raymond Kim, Alan So	VIEW
Group 2: Understanding and Improving Survivorship Issues	Jennifer Jones, Christina Canil	VIEW
Group 3: Optimizing/Personalizing RCC therapy	Georg Bjarnason, Sebastien Hotte	VIEW
Group 4: Advancing Diagnostic Abilities and Techniques in RCC	Luke Lavallée, Pierre Karakewicz	VIEW
Progress Report, Grant Winners and Future Discussion	Anil Kapoor	VIEW